Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP472336.RAgk7CJ57rwUUnfHaEtB8tH1nOVzDog5Clr9-ftDPn96g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP472336.RAgk7CJ57rwUUnfHaEtB8tH1nOVzDog5Clr9-ftDPn96g130_assertion type Assertion NP472336.RAgk7CJ57rwUUnfHaEtB8tH1nOVzDog5Clr9-ftDPn96g130_head.
- NP472336.RAgk7CJ57rwUUnfHaEtB8tH1nOVzDog5Clr9-ftDPn96g130_assertion wasGeneratedBy ECO_0000203 NP472336.RAgk7CJ57rwUUnfHaEtB8tH1nOVzDog5Clr9-ftDPn96g130_provenance.
- NP472336.RAgk7CJ57rwUUnfHaEtB8tH1nOVzDog5Clr9-ftDPn96g130_assertion wasDerivedFrom befree-20140225 NP472336.RAgk7CJ57rwUUnfHaEtB8tH1nOVzDog5Clr9-ftDPn96g130_provenance.
- NP472336.RAgk7CJ57rwUUnfHaEtB8tH1nOVzDog5Clr9-ftDPn96g130_assertion SIO_000772 17602077 NP472336.RAgk7CJ57rwUUnfHaEtB8tH1nOVzDog5Clr9-ftDPn96g130_provenance.
- NP472336.RAgk7CJ57rwUUnfHaEtB8tH1nOVzDog5Clr9-ftDPn96g130_assertion evidence source_evidence_literature NP472336.RAgk7CJ57rwUUnfHaEtB8tH1nOVzDog5Clr9-ftDPn96g130_provenance.
- NP472336.RAgk7CJ57rwUUnfHaEtB8tH1nOVzDog5Clr9-ftDPn96g130_assertion description "[To evaluate the immunological and clinical response as well as the safety of the optimized peptide telomerase reverse transcriptase p572Y (TERT572Y) presented by HLA-A*0201 in patients with advanced non-small-cell lung cancer (NSCLC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP472336.RAgk7CJ57rwUUnfHaEtB8tH1nOVzDog5Clr9-ftDPn96g130_provenance.